Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase.

Slides:

Advertisements

Similar presentations

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

Advertisements

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

Uric Acid and Long-term Outcomes in CKD

Evaluation of Kidney Donors: Core Curriculum 2018

Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis Patricia M.

Dialysis Catheter–Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap Jeffrey L. Hymes, MD, Ann.

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.

Olivier Niel, MD, PhD, Charlotte Boussard, MSc, Paul Bastard, MSc

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline Krista L. Lentine, MD, PhD, Andrew S. Levey, MD,

Metabolic Complications in Elderly Adults With CKD

Development of Reduced Kidney Function in Rheumatoid Arthritis

Francesca Mallamaci, MD, Giovanni Tripepi, PhD

Empirically Derived Search Filters for the Development of Kidney Disease Clinical Practice Guidelines Pavel S. Roshanov, MD, MSc, Arthur V. Iansavichus,

A Decade After the KDOQI CKD Guidelines

Erratum Regarding “Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials” (Am.

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind,

Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind,

This Month in AJKD American Journal of Kidney Diseases

Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study Simon Sawhney, MBChB, Angharad.

Matei Neagu, PhD, Daniel Coca, PhD, Albert C.M. Ong, DM

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Quiz Page July 2009 American Journal of Kidney Diseases

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Evaluation of the Potential Living Kidney Donor

Acute Kidney Injury and Death Associated With Renin Angiotensin System Blockade in Cardiothoracic Surgery: A Meta-analysis of Observational Studies Rabi.

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Daniel E. Weiner, MD, MS American Journal of Kidney Diseases

Salt and Hypertension American Journal of Kidney Diseases

Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis Xiaole Su, MD, Lu Zhang, MD, Jicheng Lv, MD, PhD, Jinwei Wang, PhD,

Ioannis Koulouridis, MD, MS, Lori Lyn Price, MAS, Nicolaos E

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis Kevin Quach,

Yousef Rezaei, MD American Journal of Kidney Diseases

Effect of Intensive Insulin Therapy and Pentastarch Resuscitation on Acute Kidney Injury in Severe Sepsis George Thomas, MD, MPH, Ethan M. Balk, MD,

This Month in AJKD American Journal of Kidney Diseases

Proteinuria and Other Urinary Biomarkers in Kidney Transplantation: Why Are We Still Waiting for Godot? Bertram L. Kasiske, MD American Journal of Kidney.

Sankar D. Navaneethan, MD, MPH, Suetonia C. Palmer, MBChB, Jonathan C

Prediabetes as a Precursor to Diabetic Kidney Disease

Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor.

Use of Diuretics in Heart Failure: A Precarious Balance

Polyunsaturated Fatty Acids and Kidney Disease

Nephrology: As It Was Then, But Is Not Now

Performance of GFR Estimating Equations Stratified by Measured or Estimated GFR: Implications for Interpretation Jonas Björk, PhD, Anders Grubb, MD,

Beef Tea, Vitality, Creatinine, and the Estimated GFR

Christina L. Klein, MD, Daniel C. Brennan, MD, FACP

American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

Evidence and Outcomes in CKD

Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation? Lionel Rostaing, Nassim Kamar Kidney International

Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial Tadao Akizawa, MD, PhD, Yasushi Asano,

Drug Dose Adjustments in Patients With Renal Impairment

Dennis G. Moledina, MD, Mark A. Perazella, MD

Erratum American Journal of Kidney Diseases

Methods for guideline development

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Quiz Page August 2007 American Journal of Kidney Diseases

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Trial Quality in Nephrology: How Are We Measuring Up?

Erratum American Journal of Kidney Diseases

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

This Month in AJKD American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Dialysis Research and N-of-1 Trials: Made for Each Other?

National Kidney Foundation's Kidney Early Evaluation Program (KEEP) Annual Data Report 2009: Executive Summary Peter A. McCullough, MD, MPH, Joseph A.

Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients Colin R. Lenihan, MB BCh, PhD, Sumi Sukumaran Nair, MD, Chandan Vangala,

Quiz page December 2003 American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

Presentation transcript:

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial Josep M. Grinyó, MD, PhD, Maria del Carmen Rial, MD, PhD, Josefina Alberu, MD, Steven M. Steinberg, MD, Roberto C. Manfro, MD, PhD, Georgy Nainan, MD, Flavio Vincenti, MD, Charlotte Jones-Burton, MD, MS, Nassim Kamar, MD, PhD American Journal of Kidney Diseases Volume 69, Issue 5, Pages 587-594 (May 2017) DOI: 10.1053/j.ajkd.2016.09.021 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Mean estimated glomerular filtration rate (eGFR) from month 1 to month 36. Abbreviations: CI, confidence interval; CNI, calcineurin inhibitor. American Journal of Kidney Diseases 2017 69, 587-594DOI: (10.1053/j.ajkd.2016.09.021) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Probability of acute rejection. Abbreviations: CI, confidence interval; CNI, calcineurin inhibitor. American Journal of Kidney Diseases 2017 69, 587-594DOI: (10.1053/j.ajkd.2016.09.021) Copyright © 2016 The Authors Terms and Conditions